BIOMAT Database Logo BIOMAT Database Logo

Skin testing in systemic cutaneous drug reactions. 1998

V A DeLeo
Department of Dermatology, St Luke's Roosevelt Hospital Center, New York, NY 10025, USA.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D019338 Polypharmacy The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992) Polymedication

Related Publications

V A DeLeo
[Cutaneous adverse drug reactions: enhanced imputation score by skin testing].
April 2001, Annales de dermatologie et de venereologie,
V A DeLeo
Drug patch testing in systemic cutaneous drug allergy.
April 2005, Toxicology,
V A DeLeo
The use of skin testing in the investigation of cutaneous adverse drug reactions.
July 1998, The British journal of dermatology,
V A DeLeo
Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons.
July 2016, The British journal of dermatology,
V A DeLeo
Systemic reactions from skin testing: literature review.
January 2006, Journal of investigational allergology & clinical immunology,
V A DeLeo
Skin reactions to systemic drug therapy.
November 1973, The Practitioner,
V A DeLeo
Systemic reactions during cutaneous testing for tetanus toxoid hypersensitivity.
August 1986, Annals of allergy,
V A DeLeo
Patch testing for nonimmediate cutaneous adverse drug reactions.
February 2018, Journal of the American Academy of Dermatology,
V A DeLeo
Isolated late cutaneous reactions to allergen skin testing in children.
March 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
V A DeLeo
Systemic reactions to measles-mumps-rubella vaccine skin testing.
April 1993, Pediatrics,
Copied contents to your clipboard!